Ben Weeder

发表论文 4 篇 · 总被引 8 次 · h-index 2

代表论文

• Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial (2026 · Nature Medicine · 被引 7)
• Activity and biomarker analyses with casdatifan (cas), a next-generation HIF-2α inhibitor, in refractory clear cell renal cell carcinoma (ccRCC): Results from ARC-20. (2026 · Journal of Clinical Oncology · 被引 2)
• Author Correction: Casdatifan shows durable response linked to HIF-2α biology in kidney cancer (2026 · Nature)
• Casdatifan shows durable response linked to HIF-2α biology in kidney cancer (2026 · Nature)